Literature DB >> 12213700

Hyaluronan and tumor growth.

Bryan P Toole1, Vincent C Hascall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213700      PMCID: PMC1867242          DOI: 10.1016/S0002-9440(10)64232-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  32 in total

1.  Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties.

Authors:  N Itano; T Sawai; M Yoshida; P Lenas; Y Yamada; M Imagawa; T Shinomura; M Hamaguchi; Y Yoshida; Y Ohnuki; S Miyauchi; A P Spicer; J A McDonald; K Kimata
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

2.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.

Authors:  T D Camenisch; A P Spicer; T Brehm-Gibson; J Biesterfeldt; M L Augustine; A Calabro; S Kubalak; S E Klewer; J A McDonald
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Hyaluronan synthase elevation in metastatic prostate carcinoma cells correlates with hyaluronan surface retention, a prerequisite for rapid adhesion to bone marrow endothelial cells.

Authors:  M A Simpson; J Reiland; S R Burger; L T Furcht; A P Spicer; T R Oegema; J B McCarthy
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

4.  Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.

Authors:  V B Lokeshwar; D Rubinowicz; G L Schroeder; E Forgacs; J D Minna; N L Block; M Nadji; B L Lokeshwar
Journal:  J Biol Chem       Date:  2001-01-19       Impact factor: 5.157

5.  Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.

Authors:  N Liu; F Gao; Z Han; X Xu; C B Underhill; L Zhang
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

6.  Enhanced transformation by a plasma membrane-associated met oncoprotein: activation of a phosphoinositide 3'-kinase-dependent autocrine loop involving hyaluronic acid and CD44.

Authors:  D M Kamikura; H Khoury; C Maroun; M A Naujokas; M Park
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide 3-kinase-Akt in a tumor-specific manner.

Authors:  Y Sohara; N Ishiguro; K Machida; H Kurata; A A Thant; T Senga; S Matsuda; K Kimata; H Iwata; M Hamaguchi
Journal:  Mol Biol Cell       Date:  2001-06       Impact factor: 4.138

Review 8.  Hyaluronan in morphogenesis.

Authors:  B P Toole
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

9.  Hyaluronan enters keratinocytes by a novel endocytic route for catabolism.

Authors:  R Tammi; K Rilla; J P Pienimaki; D K MacCallum; M Hogg; M Luukkonen; V C Hascall; M Tammi
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

Review 10.  CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression.

Authors:  L Y Bourguignon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

View more
  32 in total

Review 1.  Heralding a new paradigm in 3D tumor modeling.

Authors:  Eliza L S Fong; Daniel A Harrington; Mary C Farach-Carson; Hanry Yu
Journal:  Biomaterials       Date:  2016-09-02       Impact factor: 12.479

2.  In vitro elucidation of the role of pericellular matrix in metastatic extravasation and invasion of breast carcinoma cells.

Authors:  Marie-Elena Brett; Heather E Bomberger; Geneva R Doak; Matthew A Price; James B McCarthy; David K Wood
Journal:  Integr Biol (Camb)       Date:  2018-04-23       Impact factor: 2.192

3.  Hyaluronan-based heparin-incorporated hydrogels for generation of axially vascularized bioartificial bone tissues: in vitro and in vivo evaluation in a PLDLLA-TCP-PCL-composite system.

Authors:  Subha N Rath; Galyna Pryymachuk; Oliver A Bleiziffer; Christopher X F Lam; Andreas Arkudas; Saey T B Ho; Justus P Beier; Raymund E Horch; Dietmar W Hutmacher; Ulrich Kneser
Journal:  J Mater Sci Mater Med       Date:  2011-03-30       Impact factor: 3.896

4.  Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.

Authors:  Katerina Kouvidi; Aikaterini Berdiaki; Dragana Nikitovic; Pavlos Katonis; Nikos Afratis; Vincent C Hascall; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 5.  Three-dimensional in vitro tumor models for cancer research and drug evaluation.

Authors:  Xian Xu; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biotechnol Adv       Date:  2014-08-10       Impact factor: 14.227

6.  Differential expression of Hyaluronic Acid Binding Protein 1 (HABP1)/P32/C1QBP during progression of epidermal carcinoma.

Authors:  Ilora Ghosh; Anindya Roy Chowdhury; Moganty R Rajeswari; Kasturi Datta
Journal:  Mol Cell Biochem       Date:  2004-12       Impact factor: 3.396

7.  Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells.

Authors:  Jeanine A Ward; Lei Huang; Huiming Guo; Shibnath Ghatak; Bryan P Toole
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

8.  Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks.

Authors:  Xian Xu; Amit K Jha; Daniel A Harrington; Mary C Farach-Carson; Xinqiao Jia
Journal:  Soft Matter       Date:  2012       Impact factor: 3.679

9.  HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization.

Authors:  Shy Chyi Wuang; Koon Gee Neoh; En-Tang Kang; Daniel W Pack; Deborah E Leckband
Journal:  Biomaterials       Date:  2008-03-04       Impact factor: 12.479

10.  Sonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning.

Authors:  Jiang Liu; Qiang Li; Michael R Kuehn; Ying Litingtung; Steven A Vokes; Chin Chiang
Journal:  Dev Biol       Date:  2013-01-08       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.